The devices were implanted and were not returned for analysis.Ischemic events and thrombosis are known inherent risks of the endovascular procedure and are documented in our device¿s instructions for use (ifu).There was no allegation that the devices did not function as desired or that a malfunction occurred during the first procedure or the second.Based on the reported information, there was no reasonably suggestion that a malfunction or quality deficiency of the pipeline device occurred during the treatment procedure.Based on the reported information, there is no evidence suggesting that the device was defective, but rather a patient condition and procedure related event.If information is provided in the future, a supplemental report will be issued.
|